platoseedplatoseed
A nonprofit stool bank enabling access to fecal transplants.
We are a nonprofit stool bank, expanding safe access to fecal transplants and catalyzing research on the human microbiome.
OpenBiome Foundation is a nonprofit focused on expanding patient access to microbiome therapies and accelerating research in microbiome health, with a history tied to providing access to investigational fecal microbiota transplantation (FMT) for C. diff and a mission to close treatment gaps by 2030. It aims to equip clinicians and researchers with tools, resources, and infrastructure to advance microbiome therapies and share high-impact resources across the community.
The foundation funds and enables access to microbiome-based therapies by investing in research, collaboration, and open-access resources. It focuses on delivering tools, knowledge, and infrastructure to clinicians, scientists, and healthcare systems to advance and deliver microbiome therapies, and develops high-impact resources to accelerate discovery and enable researchers to build on each other’s work. It also engages in grant making and thought leadership to support the field.
Who it’s for: Clinicians, researchers, healthcare systems, and scientists focused on microbiome therapies and C. diff treatment.
Notable fundraising/grant activities and strategic collaboration announcements; long-term roadmap through 2030
Co-founder, OpenBiome. Physician scientist researching the role of the microbiome in human health.
Carolyn Edelstein is OpenBiome’s Executive Director. She previously worked at Development Innovation Ventures, a program at USAID designed to fund ideas that could improve millions of lives in more cost-effective ways than standard international development approaches. Carolyn helped launch the Global Innovation Fund, a $200M multilateral development fund built on the DIV model, before co-founding OpenBiome.
We are using the gut microbiome to end cancer.
We make bacteria and plants that clean up pollution.
